Colbert, Robert
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #141
- Top 1% Funded
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$13.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#141
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Colbert, Robert as a PI. Multi-PI records show the full award amount for context.
- 1ZIDAR041180-16ZIDContact PIClinical Support Services for the NIAMS Intramural Research Program$11.6Maward amount
- 1ZIAAR041184-15ZIAContact PIPathogenic Mechanisms in Spondyloarthritis$1.7Maward amount
Award organization
Organizations that administered FY2023 awards listing Colbert, Robert as a PI.
FY2023 award administered by National Institute of Arthritis and Musculoskeletal and Skin Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardNational Institute of Arthritis and Musculoskeletal and Skin Diseases
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #5644
- 2010$2M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #3394
- 2011$5M Cumulative Funding
- 2011Entered Top 10% NationallyRanked #1804
- 2013$10M Cumulative Funding
- 2017$25M Cumulative Funding
- 2017Entered Top 5% NationallyRanked #982
- 2018Entered Top 1% NationallyRanked #126
- 2021$50M Cumulative Funding